SXI Life Sciences
7.772,36
PKT
-3,32
PKT
-0,04
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Leider sind zu diesem Wert keine aktuellen Kursdaten verfügbar, die Stammdaten finden Sie im unteren Seitenbereich.
Analysen zu SXI Life Sciences-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 03.06.20 | Novartis Conviction Buy | Goldman Sachs Group Inc. | |
| 01.06.20 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 29.05.20 | Roche buy | Jefferies & Company Inc. | |
| 29.05.20 | Roche overweight | JP Morgan Chase & Co. | |
| 27.05.20 | Roche overweight | JP Morgan Chase & Co. | |
| 21.05.20 | Novartis Neutral | UBS AG | |
| 18.05.20 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 15.05.20 | Roche kaufen | Barclays Capital | |
| 14.05.20 | Roche buy | UBS AG | |
| 14.05.20 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 14.05.20 | Roche overweight | JP Morgan Chase & Co. | |
| 13.05.20 | Roche buy | UBS AG | |
| 11.05.20 | Novartis Neutral | UBS AG | |
| 08.05.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 05.05.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 30.04.20 | Novartis Hold | HSBC | |
| 30.04.20 | Roche Hold | HSBC | |
| 29.04.20 | Novartis Neutral | Credit Suisse Group | |
| 29.04.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 28.04.20 | Roche buy | UBS AG | |
| 28.04.20 | Novartis Neutral | UBS AG | |
| 28.04.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 28.04.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 28.04.20 | Novartis buy | Jefferies & Company Inc. | |
| 27.04.20 | Roche overweight | Morgan Stanley | |
| 24.04.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 24.04.20 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 23.04.20 | Roche buy | UBS AG | |
| 23.04.20 | Roche overweight | JP Morgan Chase & Co. | |
| 23.04.20 | Roche Neutral | Credit Suisse Group | |
| 22.04.20 | Roche overweight | JP Morgan Chase & Co. | |
| 22.04.20 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 22.04.20 | Roche buy | Jefferies & Company Inc. | |
| 20.04.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 17.04.20 | Roche overweight | JP Morgan Chase & Co. | |
| 16.04.20 | Roche overweight | JP Morgan Chase & Co. | |
| 15.04.20 | Roche buy | Jefferies & Company Inc. | |
| 15.04.20 | Novartis buy | Jefferies & Company Inc. | |
| 09.04.20 | Roche overweight | Barclays Capital | |
| 07.04.20 | Roche Conviction Buy List | Goldman Sachs Group Inc. |